Public BoD papers 26.5.22

4. Care Quality Commission and medical care oncology indicators Medical care core service risk models are being developed that involve sentinel metrics and then a deep dive into data sources facilitated by CQC data and insight colleagues with a specialist cancer clinician. The regulatory activity outcome from a deep dive could range from no regulatory action needed, monitor specific information to check for worsening performance, engagement call, or propose focused inspection. Oncology indicators are required in respect of the medical care core service focusing initially on cancer treatment and acute oncology services. Cancer diagnostic and cancer surgery pathways are out of the scope of this project currently. The proposed model of those indicators in scope includes, Acute Oncology, Systemic Anti-Cancer Treatments (SACT) and Radiotherapy. Based on the draft oncology indicators provided by CQC the Christie already have systems in place for collecting and reported these indicators. Further work is need by us to fully address the Acute Oncology data required. Patient reported outcomes (PROs) such as quality of life are also included in the oncology indicators. As an organisation we are already at the forefront of collecting PRO data which includes quality of life. 5. The Specialised Services CQUIN Scheme One CQUIN Scheme (2022/23) has been identified by the national commissioning team as applicable for the Trust to undertake, which is Shared Decision Making (SDM). The undertaking of this CQUIN is being reviewed in relation to the identification of patient cohorts. We plan to utilise the ePROMs platform to collect patients’ experience and perceptions of SDM. This project will be monitored through the Patient Experience Committee and supported by the Chief Nurse and Medical Director. There may be financial penalties for a Trust that does not adequately comply with this CQUIN.

87